Skip to content

The cross-sectional validity of three measurement instruments for central sensitization

The cross-sectional validity of three measurement instruments for central sensitization - Measuring central sensitization

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44607
Enrollment
70
Registered
2014-12-24
Start date
2015-09-07
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diverse aandoeningen (b.v. fibromyalgie, whiplash, vermoeidheidssyndroom) waarbij centrale sensitisatie vaak aanwezig is chronic painsyndrome somatization

Interventions

None listed

Sponsors

Medisch Centrum Alkmaar
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Group 1 (n

Exclusion criteria

Exclusion criteria: - neuropathic pain - severe diseases like cancer - pregnant - cardiovascular diseases - neurological diseases - diabetes.

Design outcomes

Primary

MeasureTime frame
Outcomes of the CSI and pain pressure thresholds [PPT]

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)